Effects of Laser Therapy and Exercise in Participants With Chronic Low Back Pain

NCT ID: NCT04287725

Last Updated: 2021-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-02

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this clinical trial is to evaluate the additional effects of Laser Therapy in participants with chronic non-specific low back pain in the short and long term.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this clinical trial is to evaluate the additional effects of Photobiomodulation Therapy in participants with chronic non-specifc low back pain in the short and long term.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain (LBP)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

exercise + active Photobiomodulation therapy (PBMT)

Exercise protocol: The program will consist of individual sessions of progressive and submaximal exercises with aerobic training on a treadmill and spine strengthening exercise.

Photobiomodulation therapy: will be performed using the active super pulsed laser (904nm).

Group Type EXPERIMENTAL

exercise + photobiomodulation therapy

Intervention Type DEVICE

Treatment sessions will be provided twice a week for 6 weeks (totaling 12 sessions) with participants receiving either placebo or active PBMT + exercise protocol.

exercise + placebo Photobiomodulation therapy (PBMT)

Exercise protocol: The program will consist of individual sessions of progressive and submaximal exercises with aerobic training on a treadmill and spine strengthening exercise.

Photobiomodulation therapy: will be performed using the placebo super pulsed laser (904nm).

Group Type PLACEBO_COMPARATOR

exercise + photobiomodulation therapy

Intervention Type DEVICE

Treatment sessions will be provided twice a week for 6 weeks (totaling 12 sessions) with participants receiving either placebo or active PBMT + exercise protocol.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

exercise + photobiomodulation therapy

Treatment sessions will be provided twice a week for 6 weeks (totaling 12 sessions) with participants receiving either placebo or active PBMT + exercise protocol.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with non-specific chronic LBP, defined as pain or discomfort between the costal margins and inferior gluteal folds with or without referred pain to the lower limbs;
* Persistent LBP for at least 3 months;
* Low back pain of intensity reported 3 or higher by the Visual Analogue Scale (VAS), at least once in the previous 7 days;
* Aged between 18 and 65 years;
* Both genders.

Exclusion Criteria

* Patients with severe skin diseases (eg, skin cancer, erysipelas, severe eczema, severe dermatitis, severe psoriasis and severe hives lupus);
* Participants with known or suspected serious spinal pathology (e.g., fractures, tumors, inflammatory, rheumatologic disorders, or infective diseases of the spine);
* Nerve root compromise;
* History of previous spinal surgery (even in a segment other than the lumbar spine) or scheduled surgery;
* Pain due to or associated with pregnancy or structural deformity (for example, scoliosis);
* Pregnancy;
* Comorbid health conditions that could prevent active participation in the exercise programs such as high blood pressure, pregnancy, or cardio-respiratory illnesses;
* Having answered "yes" to any of the questions in the Physical Activity Readiness Questionnaire (PAR-Q);
* Be treated with PBMT;
* Being under physiotherapeutic treatment or perform physical exercise;
* Who are using NSAID or start it during the trial;
* Who have inability to tolerate the proposed experimental procedures (such as tests of mobility and strength of the lumbar muscles).
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federal University of the Valleys of Jequitinhonha and Mucuri

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Flávia Santos

Role: PRINCIPAL_INVESTIGATOR

Federal University of the Valleys of Jequitinhonha and Mucuri

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Murilo Oliveira

Role: CONTACT

3532-1200 ext. 8972

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18022020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.